|
PLEKHG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.73929800854012E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75439995864224E-10 |
| Normal-vs-Stage2 |
4.76620000000594E-06 |
| Normal-vs-Stage3 |
1.85447999999644E-05 |
| Normal-vs-Stage4 |
1.93557000000011E-05 |
| Stage1-vs-Stage2 |
6.305800E-01 |
| Stage1-vs-Stage3 |
3.940400E-01 |
| Stage1-vs-Stage4 |
6.215400E-01 |
| Stage2-vs-Stage3 |
8.086400E-01 |
| Stage2-vs-Stage4 |
3.769400E-01 |
| Stage3-vs-Stage4 |
3.232400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02490246792308E-11 |
| Normal-vs-AfricanAmerican |
2.39950000002764E-06 |
| Normal-vs-Asian |
2.801000E-03 |
| Caucasian-vs-AfricanAmerican |
1.728570E-01 |
| Caucasian-vs-Asian |
8.031000E-01 |
| AfricanAmerican-vs-Asian |
6.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87649895622144E-12 |
| Normal-vs-Female |
5.9083999999987E-05 |
| Male-vs-Female |
2.744000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.66180000047167E-07 |
| Normal-vs-Extreme_Weight |
1.62503344114384E-12 |
| Normal-vs-Obese |
7.74349999677071E-08 |
| Normal-vs-Extreme_Obese |
1.02020000003478E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.494000E-01 |
| Normal_Weight-vs-Obese |
3.050800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.338400E-01 |
| Extreme_Weight-vs-Obese |
6.302100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.759600E-01 |
| Obese-vs-Extreme_Obese |
7.908400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.615890E-02 |
| Normal-vs-Age(41-60Yrs) |
1.3659962050383E-11 |
| Normal-vs-Age(61-80Yrs) |
5.31739996478819E-09 |
| Normal-vs-Age(81-100Yrs) |
4.08280076413803E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.382400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.721700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.777800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.378400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.579900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.301700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
1.32116539930394E-14 |
| Normal-VS-KIRP CIMP |
9.083800E-01 |
| Normal-VS-Unclassified PRCC |
1.5379900000001E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.537600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.82699999573543E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.938400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.76019999686972E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
8.103800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.358020E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.47719614318476E-11 |
| Normal-vs-N1 |
1.016540E-03 |
| Normal-vs-N2 |
1.455740E-02 |
| N0-vs-N1 |
7.463200E-03 |
| N0-vs-N2 |
3.389200E-01 |
| N1-vs-N2 |
5.442800E-01 |
|
|
